Requirement for CD154 in the progression of atherosclerosis

[1]  P. Groot,et al.  Chemokines and atherosclerosis. , 1999, Atherosclerosis.

[2]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[3]  H. Wellens,et al.  Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. , 1999, Cardiovascular research.

[4]  P. Doevendans,et al.  Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. , 1999, Circulation.

[5]  R. Terkeltaub,et al.  Chemokines and atherosclerosis. , 1998, Current opinion in lipidology.

[6]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[7]  D. Richman,et al.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Libby,et al.  CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.

[9]  P. Libby,et al.  Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? , 1997, Circulation research.

[10]  P. Libby,et al.  Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.

[11]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[12]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Mayadas,et al.  Absence of P-selectin delays fatty streak formation in mice. , 1997, The Journal of clinical investigation.

[15]  R. Flavell,et al.  A central role of CD40 ligand in the regulation of CD4+ T-cell responses. , 1996, Immunology today.

[16]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[17]  A. Matsushima,et al.  Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals , 1995, The Journal of experimental medicine.

[18]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[19]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.

[20]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  J. Bajorath,et al.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.

[22]  E. Döpp,et al.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.